Sign in

CIK 0001703647

  • Non-accelerated filer
  • Smaller reporting company

Korro Bio, Inc.

Sign in to watch
Ticker
KRRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472324450
Phone
+1 617-468-1999
Business address
60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
Former names
Frequency Therapeutics, Inc.
Open-market buys, last 90 days
$884,752
in 1 filing
Open-market sales, last 90 days
$1,763,410
in 5 filings, $1.8M under 10b5-1 plans

Net −$878,658. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-08-17 MARCUS JOEL S Director Grant or award · Stock Option +14,846 14,846
2022-08-17 MARCUS JOEL S Director Returned to the company · Stock Option −14,846 0
2022-08-17 LANGER ROBERT Director Grant or award · Stock Option +14,846 14,846
2022-08-17 LANGER ROBERT Director Returned to the company · Stock Option −14,846 0
2022-08-17 LANGER ROBERT Director Grant or award · Stock Option +14,846 14,846
2022-08-17 LANGER ROBERT Director Returned to the company · Stock Option −14,846 0
2022-08-17 Huang Michael Director Grant or award · Stock Option +14,846 14,846
2022-08-17 Huang Michael Director Returned to the company · Stock Option −14,846 0
2022-08-17 Huang Michael Director Grant or award · Stock Option +14,846 14,846
2022-08-17 Huang Michael Director Returned to the company · Stock Option −14,846 0
2022-08-17 Lucchino David L. President and CEO Grant or award · Stock Option +714,413 714,413
2022-08-17 Lucchino David L. President and CEO Returned to the company · Stock Option −714,413 0
2022-08-17 Lucchino David L. President and CEO Grant or award · Stock Option +242,500 242,500
2022-08-17 Lucchino David L. President and CEO Returned to the company · Stock Option −242,500 0
2022-08-17 Lucchino David L. President and CEO Grant or award · Stock Option +200,000 200,000
2022-08-17 Lucchino David L. President and CEO Returned to the company · Stock Option −200,000 0
2022-08-17 LeBel Carl Chief Development Officer Grant or award · Stock Option +178,937 178,937
2022-08-17 LeBel Carl Chief Development Officer Returned to the company · Stock Option −178,937 0
2022-08-17 LeBel Carl Chief Development Officer Grant or award · Stock Option +75,000 75,000
2022-08-17 LeBel Carl Chief Development Officer Returned to the company · Stock Option −75,000 0

Page 17 of 23 · 441 trades